Lumen reads routine blood tests, pathology slides, screening photos and CT scans for early signs of cancer. Every flag comes with its evidence, and a clinician makes the call. Built for hospitals in India and the United States.
What Lumen reads
Routine blood tests
7 CBC results over 26 months
What the clinician sees
For reviewWhy it was flagged
Suggested: consider FIT or colonoscopy
Treating physician decides
Fictional example. Lumen suggests; it never diagnoses.
Pick a data type to see what Lumen reads and what it shows the clinician.
Early signs are often already in the record: a slowly falling blood count, a small lesion on a scan taken for something else, a patch seen at a screening camp. Lumen is being built to help clinicians notice them sooner.
United States
3%
five-year survival when pancreatic cancer is found late, versus 44% when found early.
Source: NCI SEER, 2016 to 2022Each module works on its own, and all of them share one patient record, so a finding in one place is seen alongside everything else.
Routine blood tests
Designed to read years of CBC and chemistry results for each patient and spot slow trends linked to colorectal, blood and liver cancers. A single result can look normal when the trend is not.
For: Physicians and lab directors
Digitized pathology slides
Designed to highlight tumor regions on biopsies, help pre-screen colorectal cancer for MSI, and support consistent HER2 (including HER2-low), Ki-67, ER and PR scoring.
For: Pathologists
Phone photos of the mouth
Aims to help health workers and dentists screen for oral cancer and pre-cancer on a phone, even offline, and follow each referral through to a specialist.
For: Health workers, dentists, oral medicine
Cervix photos and Pap or LBC slides
Aims to make visual screening after acetic acid more consistent in primary care, and to help labs prioritise cytology slides.
For: Gynecologists, screening programs, labs
Routine chest and abdomen CT
Designed to take a second look at scans taken for other reasons, for early pancreatic, lung, liver or kidney findings the report may not mention.
For: Radiologists
Breast ultrasound
Support for handheld breast ultrasound where mammography is hard to reach.
For: Breast clinics, screening programs
One view of every early signal across a patient's tests, slides and scans.
Help with the growing load of biomarker scoring and biopsy review.
A quiet second look at routine scans, flagged only when it matters.
Phone-based oral and cervical screening that follows every referral.
Lumen is designed to link to your lab system, PACS, slide scanners and records, so teams keep working in the tools they know.
Each new test, slide or scan is read in the context of the patient's history, not on its own.
Findings are raised with the trends, regions or slices behind them, at a sensitivity your hospital sets.
The doctor accepts, edits or rejects every finding. Nothing reaches the record without a clinician.
A blood trend, a slide and a scan can each look minor on their own. Lumen is designed to bring them together on one patient timeline, so the oncologist, pathologist and radiologist see the same picture at the same time.
New AI should earn its place in a clinic. Lumen is designed to be introduced carefully, with your clinicians in control at every step.
Before anyone relies on it, Lumen is meant to be checked against your hospital's past, confirmed cases.
It can run in the background and be compared with real outcomes before findings are shown to doctors.
Start with the department that is ready. Expand only when your clinicians are confident.
Every override is recorded, so your team can see how Lumen performs month by month.
Detection AI is only useful if clinicians can trust it. These limits are part of how Lumen is built.
It will
It won't
In India, the biggest gap is reaching people early enough. In the US, it is giving specialists a second look across a growing volume of slides and scans. Lumen is being designed for both from day one.
India
United States
Designed to run on-premise or in your private cloud, so slides, scans and records stay where they are.
Built with the privacy rules of India and the US in mind, alongside the rest of the Healytix platform.
Each finding is kept with its inputs and the clinician's decision, ready for review.
Your clinical safety lead can pause any module at any time, without waiting on us.
Lumen runs on the Healytix Platform. Relay brings in lab, imaging and pathology data, Fabric holds the longitudinal record, Sage grounds case summaries in cited evidence, and Pulse powers cohort analytics.
Something else on your mind? Write to contact@healytix.com.
No. Lumen is designed to flag findings for a clinician to review, with the evidence behind each one. Diagnosis and treatment decisions stay with your doctors.
Data most hospitals already collect: blood test results, digitized pathology slides, routine CT scans, and photos taken during oral or cervical screening.
Lumen is designed to run on-premise or in your private cloud, so patient records stay in your environment.
Not yet. Lumen is in early access and is not approved for clinical diagnosis. We are building it to medical device standards and will share regulatory updates as they happen.
Yes. The blood and CT modules work with data most hospitals already hold digitally. Pathology support can be added once slide scanning is in place.
Most tools do one task on one kind of data. Lumen is designed to bring blood tests, slides, screening photos and scans together on one platform and one patient timeline, for hospitals in both India and the US.
We are looking for early partners: cancer centres, hospitals, labs, screening programs and researchers. Write to us and we will set up a conversation.
Lumen is open to early partners in India and the US.
Lumen is in early access and under development. It is not approved by any regulator for clinical use and is not intended for diagnosis or treatment decisions. Statistics are from the public sources linked above. Patient examples on this page are fictional.